Proteomic characterization of freeze-dried human plasma: Providing treatment of bleeding disorders without the need for a cold chain

Transfusion

Volumn 48, Issue 11, 2008, Pages 2356-2363

  Steil, Leif ^b   Thiele, Thomas ^b   Hammer, Elke ^b   Bux, Jürgen ^b   Kalus, Monika ^b   Völker, Uwe ^b   Greinacher, Andreas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR;

ARTICLE; BLEEDING DISORDER; FREEZE DRYING; PLASMA TRANSFUSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BLOOD PRESERVATION; BLOOD PROTEIN ELECTROPHORESIS; BLOOD PROTEINS; DETERGENTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FILTRATION; FREEZE DRYING; HEMORRHAGIC DISORDERS; HUMANS; MASS SPECTROMETRY; PLASMA; PROTEIN DENATURATION; PROTEOMICS; REFRIGERATION; SOLVENTS; TEMPERATURE; TIME FACTORS; VIRUS INACTIVATION;

EID: 55349089928     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01856.x     Document Type: Article

References (19)

1. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, Cocanour CS, Balldin BC, McKinley BA. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007 62 : 112 9.
2. Hellstern P, Haubelt H. Indications for plasma in massive transfusion. Thromb Res 2002 107 Suppl 1 : S19 22.
3. Bakaltcheva I, O'Sullivan A M, Hmel P, Ogbu H. Freeze-dried whole plasma: evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers. Thromb Res 2006.
4. Statement on normal (whole, pooled) human plasma prepared by Committee on Plasma and Plasma Substitutes of the Division of Medical Sciences, National Research Council. Transfusion 1968 8 : 57 9.
5. Horowitz B, Wiebe ME, Lippin A, Stryker MH. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 1985 25 : 516 22.
6. Hellstern P. Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 2004 11 : 346 50.
7. Trobisch H. Results of a quality-control study of lyophilized pooled plasmas which have been "virally inactivated" using a solvent detergent method (modified Horowitz procedure). Beitr Infusionsther 1991 28 : 92 109.
8. Hugler P, Trobisch H, Neumann HA, Möller JH, Sirtl C, Derdak M, Laubenthal H. Quality control studies of 3 deep-frozen coagulation-active fresh frozen plasma preparations from various suppliers and a new virus-inactivated lyophilized pooled plasma preparation Klin Wochenschr 1991 69 Suppl 26 : 157 61.
9. Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992 79 : 826 31.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 54.
11. Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Völker U, Greinacher A. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007 47 : 1221 33.
12. Brigulla M, Thiele T, Scharf C, Breitner-Ruddock S, Venz S, Völker U, Greinacher A. Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex concentrates. Transfusion 2006 46 : 377 85.
13. Tannu NS, Hemby SE. Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nat Protoc 2006 1 : 1732 42.
14. Thiele T, Steil L, Volker U, Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 2007 21 : 179 93.
15. Friedman DB, Lilley KS. Optimizing the difference gel electrophoresis (DIGE) technology. Methods Mol Biol 2007 428 : 93 124.
16. Pock K, Rizzi A, Josic D. Use of high-resolution techniques for the characterization of clotting factor VIII. J Chromatogr A 1999 852 : 175 88.
17. Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, Seitz R, Heiden M. Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? Transfus Med 2006 16 : 266 75.
18. Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003 14 : 283 7.
19. Thon JN, Schubert P, Duguay M, Serrano K, Lin S, Kast J, Devine DV. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008 48 : 425 35.